Author： Alvarez E. Bobes J. Gomez J.-C. Sacristan J.A. Canas F. Carrasco J.L. Gascon J. Gibert J. Gutierrez M. for the EUROPA Study Group
Publisher： Elsevier
ISSN： 0924-977X
Source： European Neuropsychopharmacology, Vol.13, Iss.1, 2003-01, pp. : 39-48
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia
By Bitter I. Dossenbach M.R.K. Brook S. Feldman P.D. Metcalfe S. Gagiano C.A. Furedi J. Bartko G. Janka Z. Banki C.M. Kovacs G. Breier A. for the Olanzapine HGCK Study Group
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. :
Conventional antipsychotics reduce rehospitalisation in schizophrenia
Inpharma, Vol. 1, Iss. 1350, 2002-01 ,pp. :